This is due to the fact that no cellular in-or efflux mechanisms have so far been described that are exclusively specific for taxanes which could at least in part explain the observations that lung cancer patients with high CAV1 expression levels had inferior survival compared to those with low expression when gemcitabine based chemotherapy was given [24]. This evidence concerns the gene CAV1 and lung cancer.